{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:07:12Z","timestamp":1790554032395,"version":"4.1.0"},"reference-count":276,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T00:00:00Z","timestamp":1594512000000},"content-version":"am","delay-in-days":285,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.nbd.2019.104526","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T11:28:46Z","timestamp":1562239726000},"page":"104526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["The neurobiological basis for novel experimental therapeutics in dystonia"],"prefix":"10.1016","volume":"130","author":[{"given":"Anthony M.","family":"Downs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn M.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone A.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen J.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5940-9028","authenticated-orcid":false,"given":"Paola","family":"Bonsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2019.104526_bb0005","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.25475","article-title":"Phenomenology and classification of dystonia: a consensus update","volume":"28","author":"Albanese","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104526_bb0010","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0015","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/cne.1186","article-title":"Muscarinic m1 and m2 receptor proteins in local circuit and projection neurons of the primate striatum: anatomical evidence for cholinergic modulation of glutamatergic prefronto-striatal pathways","volume":"434","author":"Alcantara","year":"2001","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2019.104526_bb0020","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0306-4522(89)90011-0","article-title":"The cellular localization of adenosine receptors in rat neostriatum","volume":"28","author":"Alexander","year":"1989","journal-title":"Neuroscience."},{"key":"10.1016\/j.nbd.2019.104526_bb0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0304-3940(96)13252-3","article-title":"Modulation of Ca2+ channels by activation of adenosine A1 receptors in rat striatal glutamatergic nerve terminals","volume":"220","author":"Ambrosio","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2019.104526_bb0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0165-6147(90)90249-8","article-title":"Dopamine receptor subtypes: beyond the D1\/D2 classification","volume":"11","author":"Andersen","year":"1990","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2019.104526_bb0035","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2152\/jmi.52.272","article-title":"Neuroimaging in human dystonia","volume":"52","author":"Asanuma","year":"2005","journal-title":"J. Med. Investig."},{"key":"10.1016\/j.nbd.2019.104526_bb0040","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1212\/01.WNL.0000149764.34953.BF","article-title":"Decreased striatal D2 receptor binding in non-manifesting carriers of the DYT1 dystonia mutation","volume":"64","author":"Asanuma","year":"2005","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2019.104526_bb0045","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.expneurol.2014.08.012","article-title":"Role of striatal NMDA receptor subunits in a model of paroxysmal dystonia","volume":"261","author":"Avchalumov","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2019.104526_bb0050","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1073\/pnas.90.6.2150","article-title":"Brain contains two forms of synaptic vesicle protein 2","volume":"90","author":"Bajjalieh","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2019.104526_bb0055","doi-asserted-by":"crossref","first-page":"14845","DOI":"10.1073\/pnas.1009874107","article-title":"Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors","volume":"107","author":"Bateup","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2019.104526_bb0060","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.neuron.2016.10.064","article-title":"Phosphodiesterase 10A inhibition improves cortico-basal ganglia function in huntington's disease models","volume":"92","author":"Beaumont","year":"2016","journal-title":"Neuron."},{"key":"10.1016\/j.nbd.2019.104526_bb0065","doi-asserted-by":"crossref","first-page":"10245","DOI":"10.1523\/JNEUROSCI.0669-16.2016","article-title":"Disruption of protein processing in the endoplasmic reticulum of DYT1 knock-in mice implicates novel pathways in dystonia pathogenesis","volume":"36","author":"Beauvais","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0070","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.neuroscience.2017.12.033","article-title":"Exploring the interaction between eIF2alpha dysregulation, acute endoplasmic reticulum stress and DYT1 dystonia in the mammalian brain","volume":"371","author":"Beauvais","year":"2018","journal-title":"Neuroscience."},{"key":"10.1016\/j.nbd.2019.104526_bb0075","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.brainres.2018.10.025","article-title":"Efficient RNA interference-based knockdown of mutant torsinA reveals reversibility of PERK-eIF2alpha pathway dysregulation in DYT1 transgenic rats in vivo","volume":"1706","author":"Beauvais","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2019.104526_bb0080","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/mds.27341","article-title":"A selective phosphodiesterase 10A inhibitor reduces L-Dopa-Induced dyskinesias in parkinsonian monkeys","volume":"33","author":"Beck","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104526_bb0085","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1021\/acschemneuro.8b00126","article-title":"Discovery and optimization of potent and CNS penetrant M5-preferring positive allosteric modulators derived from a novel, Chiral N-(Indanyl)piperidine amide scaffold","volume":"9","author":"Bender","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0090","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1093\/brain\/awt282","article-title":"Striatal dopaminergic dysfunction at rest and during task performance in writer's cramp","volume":"136","author":"Berman","year":"2013","journal-title":"Brain."},{"key":"10.1016\/j.nbd.2019.104526_bb0095","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/mds.25920","article-title":"The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque model","volume":"29","author":"Bezard","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104526_bb0100","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/brain\/117.4.859","article-title":"The behavioural and motor consequences of focal lesions of the basal ganglia in man","volume":"117","author":"Bhatia","year":"1994","journal-title":"Brain."},{"key":"10.1016\/j.nbd.2019.104526_bb0105","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/ana.20108","article-title":"Basal ganglia activity remains elevated after movement in focal hand dystonia","volume":"55","author":"Blood","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2019.104526_bb0110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.expneurol.2016.10.013","article-title":"Altered postnatal maturation of striatal GABAergic interneurons in a phenotypic animal model of dystonia","volume":"287","author":"Bode","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2019.104526_bb0115","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1021\/acsmedchemlett.7b00279","article-title":"Design and synthesis of mGlu2 NAMs with improved potency and CNS penetration based on a truncated picolinamide core","volume":"8","author":"Bollinger","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.nbd.2019.104526_bb0120","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/B978-0-444-64189-2.00017-2","article-title":"The cerebellum and dystonia","volume":"155","author":"Bologna","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.nbd.2019.104526_bb0125","doi-asserted-by":"crossref","first-page":"6258","DOI":"10.1523\/JNEUROSCI.1678-08.2008","article-title":"Loss of muscarinic autoreceptor function impairs long-term depression but not long-term potentiation in the striatum","volume":"28","author":"Bonsi","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2011.00006","article-title":"Centrality of striatal cholinergic transmission in basal ganglia function","volume":"5","author":"Bonsi","year":"2011","journal-title":"Front. Neuroanat."},{"issue":"1","key":"10.1016\/j.nbd.2019.104526_bb0135","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809283","article-title":"RGS9-2 rescues dopamine D2 receptor levels and signaling in DYT1 dystonia mouse models","volume":"11","author":"Bonsi","year":"2019","journal-title":"EMBO Mol Med."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2019.104526_bb0140","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1097\/00002826-198300061-00008","article-title":"Amantadine in the management of extrapyramidal side effects","volume":"6","author":"Borison","year":"1983","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.nbd.2019.104526_bb0145","doi-asserted-by":"crossref","first-page":"8452","DOI":"10.1073\/pnas.1000496107","article-title":"The basal ganglia communicate with the cerebellum","volume":"107","author":"Bostan","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2019.104526_bb0150","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41583-018-0002-7","article-title":"The basal ganglia and the cerebellum: nodes in an integrated network","volume":"19","author":"Bostan","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0155","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0397-17.2018","article-title":"Targeted activation of cholinergic interneurons accounts for the modulation of dopamine by striatal nicotinic receptors","volume":"5","author":"Brimblecombe","year":"2018","journal-title":"eNeuro."},{"key":"10.1016\/j.nbd.2019.104526_bb0160","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1212\/WNL.0b013e3181e620ae","article-title":"Clinical and biochemical features of aromatic L-amino acid decarboxylase deficiency","volume":"75","author":"Brun","year":"2010","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2019.104526_bb0165","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1212\/WNL.36.2.160","article-title":"Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidyl","volume":"36","author":"Burke","year":"1986","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2019.104526_bb0170","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1046\/j.1460-9568.2003.02588.x","article-title":"Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine-induced seizure activity","volume":"17","author":"Bymaster","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0175","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1016\/j.celrep.2018.11.053","article-title":"Dopamine cells differentially regulate Striatal cholinergic transmission across regions through corelease of dopamine and glutamate","volume":"25","author":"Cai","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2019.104526_bb0180","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nn.4306","article-title":"Hyperkinetic disorders and loss of synaptic downscaling","volume":"19","author":"Calabresi","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0185","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nn.2753","article-title":"The neural substrates of rapid-onset Dystonia-Parkinsonism","volume":"14","author":"Calderon","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0190","doi-asserted-by":"crossref","first-page":"20851","DOI":"10.1074\/jbc.M111.335273","article-title":"Cannabinoid receptors CB1 and CB2 form functional heteromers in brain","volume":"287","author":"Callen","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2019.104526_bb0195","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/mds.10127","article-title":"Impact of cervical dystonia on quality of life","volume":"17","author":"Camfield","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104526_bb0200","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/exnr.1999.7171","article-title":"Tottering mouse motor dysfunction is abolished on the Purkinje cell degeneration (pcd) mutant background","volume":"160","author":"Campbell","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2019.104526_bb0205","doi-asserted-by":"crossref","first-page":"46741","DOI":"10.1074\/jbc.M306451200","article-title":"Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer","volume":"278","author":"Canals","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2019.104526_bb0210","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1212\/01.WNL.0000120541.97467.FE","article-title":"Regional metabolism in primary torsion dystonia: effects of penetrance and genotype","volume":"62","author":"Carbon","year":"2004","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2019.104526_bb0215","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1212\/WNL.0b013e31827f0798","article-title":"Metabolic changes in DYT11 myoclonus-dystonia","volume":"80","author":"Carbon","year":"2013","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2019.104526_bb0220","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1113\/jphysiol.2008.159905","article-title":"A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS","volume":"586","author":"Cheeran","year":"2008","journal-title":"J. Physiol."},{"key":"10.1016\/j.nbd.2019.104526_bb0225","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.parkreldis.2013.06.004","article-title":"Association of the Val66Met polymorphism of the BDNF gene with primary cranial-cervical dystonia patients from South-west China","volume":"19","author":"Chen","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2019.104526_bb0230","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1517\/14656560903426171","article-title":"Treatment strategies for dystonia","volume":"11","author":"Cloud","year":"2010","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.nbd.2019.104526_bb0235","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev.pharmtox.37.1.205","article-title":"Pharmacology and functions of metabotropic glutamate receptors","volume":"37","author":"Conn","year":"1997","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.nbd.2019.104526_bb0240","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nrn1763","article-title":"Metabotropic glutamate receptors in the basal ganglia motor circuit","volume":"6","author":"Conn","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0245","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/00207458608985678","article-title":"Open label evaluation of cannabidiol in dystonic movement disorders","volume":"30","author":"Consroe","year":"1986","journal-title":"Int J Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0250","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1046\/j.1471-4159.2001.00201.x","article-title":"Galpha(olf) is necessary for coupling D1 and A2a receptors to adenylyl cyclase in the striatum","volume":"76","author":"Corvol","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2019.104526_bb0255","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nature11846","article-title":"Concurrent activation of striatal direct and indirect pathways during action initiation","volume":"494","author":"Cui","year":"2013","journal-title":"Nature."},{"key":"10.1016\/j.nbd.2019.104526_bb0260","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.bbr.2011.10.002","article-title":"An anticholinergic reverses motor control and corticostriatal LTD deficits in Dyt1 DeltaGAG knock-in mice","volume":"226","author":"Dang","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2019.104526_bb0265","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1523\/JNEUROSCI.3207-15.2016","article-title":"Phosphodiesterase-10A inverse changes in striatopallidal and striatoentopeduncular pathways of a transgenic mouse model of DYT1 dystonia","volume":"37","author":"D'Angelo","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnana.2016.00001","article-title":"Extrinsic sources of cholinergic innervation of the striatal complex: a whole-brain mapping analysis","volume":"10","author":"Dautan","year":"2016","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.nbd.2019.104526_bb0275","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0361-9230(90)90186-4","article-title":"Muscarinic and dopaminergic receptor subtypes on striatal cholinergic interneurons","volume":"25","author":"Dawson","year":"1990","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2019.104526_bb0280","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.coph.2008.12.002","article-title":"Getting specialized: presynaptic and postsynaptic dopamine D2 receptors","volume":"9","author":"De Mei","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2019.104526_bb0285","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-1331.2010.03053.x","article-title":"The epidemiology of primary dystonia: current evidence and perspectives","volume":"17","author":"Defazio","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2019.104526_bb0290","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00702-010-0526-0","article-title":"Pharmacological characterization of MRZ-8676, a novel negative allosteric modulator of subtype 5 metabotropic glutamate receptors (mGluR5): focus on L: -DOPA-induced dyskinesia","volume":"118","author":"Dekundy","year":"2011","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.nbd.2019.104526_bb0295","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0166-2236(90)90110-V","article-title":"Primate models of movement disorders of basal ganglia origin","volume":"13","author":"DeLong","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0300","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1080\/14712598.2016.1183641","article-title":"Engineered BDNF producing cells as a potential treatment for neurologic disease","volume":"16","author":"Deng","year":"2016","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.nbd.2019.104526_bb0305","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1007\/s00018-012-1252-6","article-title":"The eIF2alpha kinases: their structures and functions","volume":"70","author":"Donnelly","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.nbd.2019.104526_bb0310","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.nbd.2019.01.012","article-title":"Trihexyphenidyl rescues the deficit in dopamine neurotransmission in a mouse model of DYT1 dystonia","volume":"125","author":"Downs","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.104526_bb0315","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1212\/01.WNL.0000094240.93745.83","article-title":"\"Motor circuit\" gray matter changes in idiopathic cervical dystonia","volume":"61","author":"Draganski","year":"2003","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2019.104526_bb0320","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.neuroimage.2009.03.057","article-title":"Genotype-phenotype interactions in primary dystonias revealed by differential changes in brain structure","volume":"47","author":"Draganski","year":"2009","journal-title":"Neuroimage."},{"key":"10.1016\/j.nbd.2019.104526_bb0325","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1046\/j.1471-4159.2003.01744.x","article-title":"Subcellular segregation of distinct heteromeric NMDA glutamate receptors in the striatum","volume":"85","author":"Dunah","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2019.104526_bb0330","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nn.2286","article-title":"D2R striatopallidal neurons inhibit both locomotor and drug reward processes","volume":"12","author":"Durieux","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0335","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/mds.21619","article-title":"Voxel based morphometry reveals specific gray matter changes in primary dystonia","volume":"22","author":"Egger","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104526_bb0340","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.410440304","article-title":"Functional brain networks in DYT1 dystonia","volume":"44","author":"Eidelberg","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2019.104526_bb0345","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1002\/mds.27470","article-title":"High frequency somatosensory stimulation in dystonia: evidence fordefective inhibitory plasticity","volume":"33","author":"Erro","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104526_bb0350","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pneurobio.2015.02.002","article-title":"Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia","volume":"127-128","author":"Eskow Jaunarajs","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2019.104526_bb0355","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1038\/sj.npp.1301617","article-title":"Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens","volume":"33","author":"Exley","year":"2008","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.nbd.2019.104526_bb0360","first-page":"177","article-title":"High-dosage anticholinergic therapy in dystonia","volume":"37","author":"Fahn","year":"1983","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.nbd.2019.104526_bb0365","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1124\/jpet.117.246348","article-title":"Dopamine receptor agonist treatment of idiopathic dystonia: a reappraisal in humans and mice","volume":"365","author":"Fan","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2019.104526_bb0370","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0306-4522(87)92962-9","article-title":"Adenosine A1 receptors in the human brain: a quantitative autoradiographic study","volume":"22","author":"Fastbom","year":"1987","journal-title":"Neuroscience."},{"key":"10.1016\/j.nbd.2019.104526_bb0375","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1460-9568.1996.tb01617.x","article-title":"Dopamine D1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopenduncular pathway and its modulation by adenosine A1 receptor-mediated mechanisms","volume":"8","author":"Ferre","year":"1996","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0380","doi-asserted-by":"crossref","first-page":"11940","DOI":"10.1073\/pnas.172393799","article-title":"Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function","volume":"99","author":"Ferre","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2019.104526_bb0385","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.2174\/138161208784480108","article-title":"An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors","volume":"14","author":"Ferre","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.nbd.2019.104526_bb0390","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/mds.26930","article-title":"Disruption in cerebellar and basal ganglia networks during a visuospatial task in cervical dystonia","volume":"32","author":"Filip","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104526_bb0395","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0169-328X(92)90173-9","article-title":"Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum","volume":"14","author":"Fink","year":"1992","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.nbd.2019.104526_bb0400","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1523\/JNEUROSCI.4896-13.2014","article-title":"M5 receptor activation produces opposing physiological outcomes in dopamine neurons depending on the receptor's location","volume":"34","author":"Foster","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0405","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.neuron.2016.08.017","article-title":"Antipsychotic-like effects of M4 positive allosteric modulators are mediated by CB2 receptor-dependent inhibition of dopamine release","volume":"91","author":"Foster","year":"2016","journal-title":"Neuron."},{"key":"10.1016\/j.nbd.2019.104526_bb0410","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/mds.1280","article-title":"Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia","volume":"17","author":"Fox","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104526_bb0415","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1600-0773.1995.tb00135.x","article-title":"Purinoceptors in the nervous system","volume":"76","author":"Fredholm","year":"1995","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.nbd.2019.104526_bb0420","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/mds.20239","article-title":"Natural history of posttraumatic cervical dystonia","volume":"19","author":"Frei","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104526_bb0425","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.22775","article-title":"A role for cerebellum in the hereditary dystonia DYT1","volume":"6","author":"Fremont","year":"2017","journal-title":"Elife."},{"key":"10.1016\/j.nbd.2019.104526_bb0430","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1152\/physrev.00004.2003","article-title":"Role of endogenous cannabinoids in synaptic signaling","volume":"83","author":"Freund","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.nbd.2019.104526_bb0435","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/ana.410390510","article-title":"GTP-cyclohydrolase I gene mutations in hereditary progressive and dopa-responsive dystonia","volume":"39","author":"Furukawa","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2019.104526_bb0440","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1113\/JP275813","article-title":"Aberrant cortical excitability reflects the loss of hand dexterity in musician's dystonia","volume":"596","author":"Furuya","year":"2018","journal-title":"J. Physiol."},{"key":"10.1016\/j.nbd.2019.104526_bb0445","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/syn.20047","article-title":"Immunolocalization of CB1 receptor in rat striatal neurons: a confocal microscopy study","volume":"53","author":"Fusco","year":"2004","journal-title":"Synapse."},{"key":"10.1016\/j.nbd.2019.104526_bb0450","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1385\/JMN:26:2-3:209","article-title":"Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function","volume":"26","author":"Fuxe","year":"2005","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0455","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0014-2999(96)00300-7","article-title":"In vivo evidence for preferential role of dopamine D3 receptor in the presynaptic regulation of dopamine release but not synthesis","volume":"308","author":"Gainetdinov","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2019.104526_bb0460","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1600-0404.1996.tb07049.x","article-title":"Basal ganglia and thalamo-cortical hypermetabolism in patients with spasmodic torticollis","volume":"94","author":"Galardi","year":"1996","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.nbd.2019.104526_bb0465","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/j.neurobiolaging.2011.06.019","article-title":"Targeting NR2A-containing NMDA receptors reduces L-DOPA-induced dyskinesias","volume":"33","author":"Gardoni","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2019.104526_bb0470","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1152\/jn.2001.85.1.468","article-title":"CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum","volume":"85","author":"Gerdeman","year":"2001","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2019.104526_bb0475","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/S1471-1931(00)00019-7","article-title":"Molecular effects of dopamine on striatal-projection pathways","volume":"23","author":"Gerfen","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0480","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJM197104222841608","article-title":"Spasmodic torticollis treated effectively by medical means","volume":"284","author":"Gilbert","year":"1971","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2019.104526_bb0485","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.neuron.2015.11.007","article-title":"Bridging the Gap: muscarinic M4 receptors promote striatal plasticity in health and disease","volume":"88","author":"Girasole","year":"2015","journal-title":"Neuron."},{"key":"10.1016\/j.nbd.2019.104526_bb0490","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/342923a0","article-title":"Alternative splicing directs the expression of two D2 dopamine receptor isoforms","volume":"342","author":"Giros","year":"1989","journal-title":"Nature."},{"key":"10.1016\/j.nbd.2019.104526_bb0495","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1523\/JNEUROSCI.4870-09.2010","article-title":"Distinct roles of GABAergic interneurons in the regulation of striatal output pathways","volume":"30","author":"Gittis","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0500","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0169-328X(99)00100-X","article-title":"NMDA receptor subunit gene expression in the rat brain: a quantitative analysis of endogenous mRNA levels of NR1Com, NR2A, NR2B, NR2C, NR2D and NR3A","volume":"69","author":"Goebel","year":"1999","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.nbd.2019.104526_bb0505","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2005.11.035","article-title":"Cannabinoid CB2 receptors: immunohistochemical localization in rat brain","volume":"1071","author":"Gong","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2019.104526_bb0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nyas.12762","article-title":"Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions","volume":"1349","author":"Gonzales","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.nbd.2019.104526_bb0515","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.celrep.2018.04.098","article-title":"Differentiating cerebellar impact on thalamic nuclei","volume":"23","author":"Gornati","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2019.104526_bb0520","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/mds.870030107","article-title":"Analysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugs","volume":"3","author":"Greene","year":"1988","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104526_bb0525","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1748-1716.1986.tb07988.x","article-title":"Nicotinic effects on the firing pattern of midbrain dopamine neurons","volume":"128","author":"Grenhoff","year":"1986","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.nbd.2019.104526_bb0530","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41593-019-0341-3","article-title":"Unique contributions of parvalbumin and cholinergic interneurons in organizing striatal networks during movement","volume":"22","author":"Gritton","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0535","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pneurobio.2004.09.005","article-title":"Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases","volume":"74","author":"Gubellini","year":"2004","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2019.104526_bb0540","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/978-3-211-45295-0_72","article-title":"Pathophysiology of dystonia","author":"Hallett","year":"2006","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.nbd.2019.104526_bb0545","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejphar.2008.10.048","article-title":"Brivaracetam and seletracetam, two new SV2A ligands, improve paroxysmal dystonia in the dt sz mutant hamster","volume":"601","author":"Hamann","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2019.104526_bb0550","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neuroscience.2017.05.051","article-title":"Alterations of M1 and M4 acetylcholine receptors in the genetically dystonic (dt(sz)) hamster and moderate antidystonic efficacy of M1 and M4 anticholinergics","volume":"357","author":"Hamann","year":"2017","journal-title":"Neuroscience."},{"key":"10.1016\/j.nbd.2019.104526_bb0555","first-page":"323","article-title":"Expression of m1 and m4 muscarinic receptor mRNA in the striatum following a selective lesion of striatonigral neurons","volume":"734","author":"Harrison","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2019.104526_bb0560","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1212\/WNL.0b013e3181e0f784","article-title":"Sensorimotor overactivity as a pathophysiologic trait of embouchure dystonia","volume":"74","author":"Haslinger","year":"2010","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2019.104526_bb0565","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/mds.21597","article-title":"An open trial of levetiracetam for segmental and generalized dystonia","volume":"22","author":"Hering","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104526_bb0570","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0006-8993(91)90970-7","article-title":"Neuronal localization of cannabinoid receptors in the basal ganglia of the rat","volume":"547","author":"Herkenham","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2019.104526_bb0575","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.neuropharm.2014.09.028","article-title":"Modulation of direct pathway striatal projection neurons by muscarinic M(4)-type receptors","volume":"89","author":"Hernandez-Flores","year":"2015","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.nbd.2019.104526_bb0580","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/WNF.0000000000000241","article-title":"A phase Ib randomized controlled study to evaluate the effectiveness of a single-dose of the NR2B selective N-Methyl-D-Aspartate antagonist MK-0657 on levodopa-induced dyskinesias and motor symptoms in patients with Parkinson disease","volume":"40","author":"Herring","year":"2017","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.nbd.2019.104526_bb0585","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/jnr.10567","article-title":"TorsinA in PC12 cells: localization in the endoplasmic reticulum and response to stress","volume":"72","author":"Hewett","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2019.104526_bb0590","doi-asserted-by":"crossref","first-page":"18091","DOI":"10.1074\/jbc.M107731200","article-title":"Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors","volume":"277","author":"Hillion","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2019.104526_bb0595","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/(SICI)1098-2396(200007)37:1<71::AID-SYN8>3.0.CO;2-K","article-title":"Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study","volume":"37","author":"Hohmann","year":"2000","journal-title":"Synapse."},{"key":"10.1016\/j.nbd.2019.104526_bb0600","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/nn1544","article-title":"The cerebellum communicates with the basal ganglia","volume":"8","author":"Hoshi","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0605","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","article-title":"Neurotrophins: roles in neuronal development and function","volume":"24","author":"Huang","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0610","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1523\/JNEUROSCI.21-06-01838.2001","article-title":"Differential subcellular localization of mGluR1a and mGluR5 in the rat and monkey Substantia nigra","volume":"21","author":"Hubert","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0615","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0169-328X(92)90107-M","article-title":"Localization of multiple dopamine receptor subtype mRNAs in human and monkey motor cortex and striatum","volume":"15","author":"Huntley","year":"1992","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.nbd.2019.104526_bb0620","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3940(95)11820-M","article-title":"GTP cyclohydrolase I gene in hereditary progressive dystonia with marked diurnal fluctuation","volume":"196","author":"Ichinose","year":"1995","journal-title":"Neurosci. Lett."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2019.104526_bb0625","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/S0387-7604(00)00136-4","article-title":"Molecular mechanisms of hereditary progressive dystonia with marked diurnal fluctuation, Segawa's disease","volume":"22","author":"Ichinose","year":"2000","journal-title":"Brain Dev."},{"key":"10.1016\/j.nbd.2019.104526_bb0630","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/mds.870040302","article-title":"Treatment of movement disorders with trihexyphenidyl","volume":"4","author":"Jabbari","year":"1989","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104526_bb0635","doi-asserted-by":"crossref","first-page":"506","DOI":"10.5334\/tohm.383","article-title":"The Anatomical Basis for Dystonia: The Motor Network Model","volume":"7","author":"Jinnah","year":"2017","journal-title":"Tremor Other Hyperkinet Mov (N Y)."},{"key":"10.1016\/j.nbd.2019.104526_bb0640","doi-asserted-by":"crossref","first-page":"280","DOI":"10.5334\/tohm.267","article-title":"The role of dopamine and dopaminergic pathways in dystonia: insights from neuroimaging","volume":"5","author":"Karimi","year":"2015","journal-title":"Tremor Other Hyperkinet Mov (N Y)."},{"key":"10.1016\/j.nbd.2019.104526_bb0645","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1523\/JNEUROSCI.13-11-04908.1993","article-title":"Physiological, morphological, and histochemical characterization of three classes of interneurons in rat neostriatum","volume":"13","author":"Kawaguchi","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0650","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-0102(96)01134-0","article-title":"Neostriatal cell subtypes and their functional roles","volume":"27","author":"Kawaguchi","year":"1997","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.nbd.2019.104526_bb0655","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/277093a0","article-title":"Multiple receptors for dopamine","volume":"277","author":"Kebabian","year":"1979","journal-title":"Nature."},{"key":"10.1016\/j.nbd.2019.104526_bb0660","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00213-005-2200-z","article-title":"Ionotropic and metabotropic glutamate receptor structure and pharmacology","volume":"179","author":"Kew","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.nbd.2019.104526_bb0665","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mds.26142","article-title":"The therapeutic potential of cannabinoids for movement disorders","volume":"30","author":"Kluger","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104526_bb0670","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s13311-015-0376-4","article-title":"Cannabis in the Treatment of Dystonia, Dyskinesias, and Tics","volume":"12","author":"Koppel","year":"2015","journal-title":"Neurotherapeutics."},{"issue":"11","key":"10.1016\/j.nbd.2019.104526_bb0675","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1093\/cercor\/bhw252","article-title":"Cortical Control of Striatal Dopamine Transmission via Striatal Cholinergic Interneurons","volume":"26","author":"Kosillo","year":"2016","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.nbd.2019.104526_bb0680","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/(SICI)1096-9861(19980105)390:1<63::AID-CNE6>3.0.CO;2-O","article-title":"Expression of N-methyl-D-aspartate receptor subunit mRNAs in the human brain: striatum and globus pallidus","volume":"390","author":"Kosinski","year":"1998","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2019.104526_bb0685","first-page":"927","article-title":"Head injury and posttraumatic movement disorders","volume":"50","author":"Krauss","year":"2002","journal-title":"Neurosurgery."},{"key":"10.1016\/j.nbd.2019.104526_bb0690","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nature09159","article-title":"Regulation of parkinsonian motor behaviors by optogenetic control of basal ganglia circuitry","volume":"466","author":"Kravitz","year":"2010","journal-title":"Nature."},{"key":"10.1016\/j.nbd.2019.104526_bb0695","doi-asserted-by":"crossref","first-page":"10537","DOI":"10.1523\/JNEUROSCI.2959-05.2005","article-title":"Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum","volume":"25","author":"Kreitzer","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0700","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1093\/cercor\/bhp135","article-title":"Segregated fronto-cerebellar circuits revealed by intrinsic functional connectivity","volume":"19","author":"Krienen","year":"2009","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.nbd.2019.104526_bb0705","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1474-4422(10)70269-6","article-title":"Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study","volume":"10","author":"Kurian","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2019.104526_bb0710","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/0269881110367732","article-title":"Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis","volume":"25","author":"Lanciego","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.nbd.2019.104526_bb0715","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1523\/JNEUROSCI.15-07-05297.1995","article-title":"NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum","volume":"15","author":"Landwehrmeyer","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0720","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1017\/S0317167100035770","article-title":"High dose anticholinergic therapy in adult dystonia","volume":"13","author":"Lang","year":"1986","journal-title":"Can J Neurol Sci."},{"key":"10.1016\/j.nbd.2019.104526_bb0725","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1017\/S0317167100044139","article-title":"Anticholinergics in adult-onset focal dystonia","volume":"9","author":"Lang","year":"1982","journal-title":"Can J Neurol Sci."},{"key":"10.1016\/j.nbd.2019.104526_bb0730","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.nbd.2010.11.006","article-title":"Animal models of dystonia: Lessons from a mutant rat","volume":"42","author":"LeDoux","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.104526_bb0735","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/mds.10301","article-title":"Secondary cervical dystonia associated with structural lesions of the central nervous system","volume":"18","author":"LeDoux","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104526_bb0740","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(84)90908-5","article-title":"Hemidystonia relieved by nicotine","volume":"2","author":"Lees","year":"1984","journal-title":"Lancet."},{"key":"10.1016\/j.nbd.2019.104526_bb0745","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/mds.25527","article-title":"The anatomical basis of dystonia: current view using neuroimaging","volume":"28","author":"Lehericy","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104526_bb0750","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bmcl.2007.12.051","article-title":"Synthesis and SAR of selective muscarinic acetylcholine receptor subtype 1 (M1 mAChR) antagonists","volume":"18","author":"Lewis","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.nbd.2019.104526_bb0755","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ana.21315","article-title":"Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces \"off\" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005)","volume":"63","author":"LeWitt","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2019.104526_bb0760","doi-asserted-by":"crossref","first-page":"301","DOI":"10.9758\/cpn.2017.15.4.301","article-title":"A systematic review of the effectiveness of medical cannabis for psychiatric, Movement and neurodegenerative disorders","volume":"15","author":"Lim","year":"2017","journal-title":"Clin Psychopharmacol Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0765","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM198111053051902","article-title":"Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome","volume":"305","author":"Lloyd","year":"1981","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2019.104526_bb0770","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1385\/NCC:3:2:139","article-title":"Identification and treatment of cervical and oromandibular dystonia in acutely brain-injured patients","volume":"3","author":"Lo","year":"2005","journal-title":"Neurocrit. Care."},{"key":"10.1016\/j.nbd.2019.104526_bb0775","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrd4024","article-title":"Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease","volume":"12","author":"Longo","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.nbd.2019.104526_bb0780","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/WNF.0b013e3181b40378","article-title":"Central levodopa influx and the clinical motor response to levodopa in patients with Parkinson disease complicated with motor fluctuations and dyskinesias","volume":"32","author":"Lopez-Ariztegui","year":"2009","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.nbd.2019.104526_bb0785","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0014-2999(00)00105-9","article-title":"Piracetam and levetiracetam, two pyrrolidone derivatives, exert antidystonic activity in a hamster model of paroxysmal dystonia","volume":"391","author":"Loscher","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2019.104526_bb0790","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/1531-8257(199901)14:1<95::AID-MDS1016>3.0.CO;2-8","article-title":"Dystonia in Huntington's disease: prevalence and clinical characteristics","volume":"14","author":"Louis","year":"1999","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104526_bb0795","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/mds.870120606","article-title":"Globus pallidus internus pallidotomy for generalized dystonia","volume":"12","author":"Lozano","year":"1997","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104526_bb0800","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ejpn.2016.02.003","article-title":"Medication use in childhood dystonia","volume":"20","author":"Lumsden","year":"2016","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.nbd.2019.104526_bb0805","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam","volume":"101","author":"Lynch","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2019.104526_bb0810","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/mds.25909","article-title":"Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model","volume":"29","author":"Mahmoudi","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104526_bb0815","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/mds.26009","article-title":"Anticholinergic drugs rescue synaptic plasticity in DYT1 dystonia: role of M1 muscarinic receptors","volume":"29","author":"Maltese","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104526_bb0820","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.nbd.2017.08.007","article-title":"Abnormal striatal plasticity in a DYT11\/SGCE myoclonus dystonia mouse model is reversed by adenosine A2A receptor inhibition","volume":"108","author":"Maltese","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.104526_bb0825","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.33331","article-title":"Early structural and functional plasticity alterations in a susceptibility period of DYT1 dystonia mouse striatum","volume":"7","author":"Maltese","year":"2018","journal-title":"Elife."},{"key":"10.1016\/j.nbd.2019.104526_bb0830","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1124\/mol.108.052886","article-title":"Discovery and characterization of novel allosteric potentiators of M1 muscarinic receptors reveals multiple modes of activity","volume":"75","author":"Marlo","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2019.104526_bb0835","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1093\/brain\/awp194","article-title":"Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine","volume":"132","author":"Martella","year":"2009","journal-title":"Brain."},{"key":"10.1016\/j.nbd.2019.104526_bb0840","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.nbd.2014.01.016","article-title":"Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia","volume":"65","author":"Martella","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.104526_bb0845","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuroscience.2005.09.005","article-title":"Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia","volume":"137","author":"Matyas","year":"2006","journal-title":"Neuroscience."},{"key":"10.1016\/j.nbd.2019.104526_bb0850","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-psych-113011-143739","article-title":"The endocannabinoid system and the brain","volume":"64","author":"Mechoulam","year":"2013","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.nbd.2019.104526_bb0855","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.36.3.445-a","article-title":"Responses to lisuride in Meige's disease and chorea","volume":"36","author":"Micheli","year":"1986","journal-title":"Neurology."},{"issue":"4","key":"10.1016\/j.nbd.2019.104526_bb0860","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1212\/WNL.32.4.432","article-title":"Beneficial effects of lisuride in Meige disease","volume":"32","author":"Micheli","year":"1982","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2019.104526_bb0865","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: from structure to function","volume":"78","author":"Missale","year":"1998","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.nbd.2019.104526_bb0870","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/342926a0","article-title":"Multiple D2 dopamine receptors produced by alternative RNA splicing","volume":"342","author":"Monsma","year":"1989","journal-title":"Nature."},{"key":"10.1016\/j.nbd.2019.104526_bb0875","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0896-6273(94)90210-0","article-title":"Developmental and regional expression in the rat brain and functional properties of four NMDA receptors","volume":"12","author":"Monyer","year":"1994","journal-title":"Neuron."},{"key":"10.1016\/j.nbd.2019.104526_bb0880","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.molmed.2018.04.001","article-title":"Neuronal regulation of eIF2alpha function in health and neurological disorders","volume":"24","author":"Moon","year":"2018","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.nbd.2019.104526_bb0885","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.pneurobio.2007.07.001","article-title":"Role of adenosine A2A receptors in parkinsonian motor impairment and l-DOPA-induced motor complications","volume":"83","author":"Morelli","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2019.104526_bb0890","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1001\/archneurpsyc.1942.02290110143009","article-title":"Amphetamine sulfate in treatment of spasmodic torticollis: report of two cases","volume":"48","author":"Myerson","year":"1942","journal-title":"Arch. Neurol. Psychiatr."},{"key":"10.1016\/j.nbd.2019.104526_bb0895","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrd3366","article-title":"Potential therapeutic uses of BDNF in neurological and psychiatric disorders","volume":"10","author":"Nagahara","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.nbd.2019.104526_bb0900","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.nbd.2010.03.003","article-title":"Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia","volume":"38","author":"Napolitano","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.104526_bb0905","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.expneurol.2004.05.004","article-title":"The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP-lesioned marmoset model of Parkinson's disease","volume":"188","author":"Nash","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2019.104526_bb0910","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/brain\/awf090","article-title":"The genetics of primary dystonias and related disorders","volume":"125","author":"Nemeth","year":"2002","journal-title":"Brain."},{"key":"10.1016\/j.nbd.2019.104526_bb0915","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1093\/brain\/awn168","article-title":"The basal ganglia and cerebellum interact in the expression of dystonic movement","volume":"131","author":"Neychev","year":"2008","journal-title":"Brain."},{"key":"10.1016\/j.nbd.2019.104526_bb0920","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.nbd.2011.01.026","article-title":"The functional neuroanatomy of dystonia","volume":"42","author":"Neychev","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.104526_bb0925","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1124\/jpet.115.226597","article-title":"VU0477573: partial negative allosteric modulator of the subtype 5 metabotropic glutamate receptor with In Vivo Efficacy","volume":"356","author":"Nickols","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2019.104526_bb0930","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1073\/pnas.0237126100","article-title":"Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling","volume":"100","author":"Nishi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2019.104526_bb0935","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","article-title":"Metabotropic glutamate receptors: physiology, pharmacology, and disease","volume":"50","author":"Niswender","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.nbd.2019.104526_bb0940","first-page":"158","article-title":"Dopamine receptor genes: new tools for molecular psychiatry","volume":"17","author":"Niznik","year":"1992","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0945","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3389\/fphar.2018.01200","article-title":"PBF509, an adenosine A2A receptor antagonist with efficacy in rodent models of movement disorders","volume":"9","author":"Nunez","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.nbd.2019.104526_bb0950","first-page":"61","article-title":"Development and anatomic localization of torsinA","volume":"94","author":"Oberlin","year":"2004","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.nbd.2019.104526_bb0955","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/mds.21495","article-title":"Morphometric changes of sensorimotor structures in focal dystonia","volume":"22","author":"Obermann","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104526_bb0960","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.nurt.2008.01.002","article-title":"Treatment of dystonia with deep brain stimulation","volume":"5","author":"Ostrem","year":"2008","journal-title":"Neurotherapeutics."},{"key":"10.1016\/j.nbd.2019.104526_bb0965","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1212\/WNL.0000000000003451","article-title":"Subthalamic nucleus deep brain stimulation in isolated dystonia: a 3-year follow-up study","volume":"88","author":"Ostrem","year":"2017","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2019.104526_bb0970","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.bmcl.2018.10.050","article-title":"The discovery of VU0652957 (VU2957, Valiglurax): SAR and DMPK challenges en route to an mGlu4 PAM development candidate","volume":"29","author":"Panarese","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.nbd.2019.104526_bb0975","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1021\/cn500003z","article-title":"M4 mAChR-mediated modulation of glutamatergic transmission at corticostriatal synapses","volume":"5","author":"Pancani","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb0980","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-0173(94)00007-C","article-title":"Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop","volume":"20","author":"Parent","year":"1995","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.nbd.2019.104526_bb0985","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/ane.12701","article-title":"Lack of efficacy of levetiracetam in oromandibular and cranial dystonia","volume":"136","author":"Park","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.nbd.2019.104526_bb0990","first-page":"447","article-title":"Procyclidine for dystonia caused by phenothiazine derivatives","volume":"21","author":"Paulson","year":"1960","journal-title":"Dis. Nerv. Syst."},{"key":"10.1016\/j.nbd.2019.104526_bb0995","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3389\/fphar.2018.00482","article-title":"Cannabidiol as a promising strategy to treat and prevent movement disorders?","volume":"9","author":"Peres","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.nbd.2019.104526_bb1000","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00702-018-1869-1","article-title":"Efficacy and safety of amantadine for the treatment of L-DOPA-induced dyskinesia","volume":"125","author":"Perez-Lloret","year":"2018","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.nbd.2019.104526_bb1005","first-page":"163","article-title":"Dysfunction of dopaminergic pathways in dystonia","volume":"94","author":"Perlmutter","year":"2004","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.nbd.2019.104526_bb1010","doi-asserted-by":"crossref","first-page":"10099","DOI":"10.1523\/JNEUROSCI.2680-04.2004","article-title":"The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology","volume":"24","author":"Pezawas","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb1015","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0306-4522(01)00297-4","article-title":"Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons","volume":"106","author":"Pisani","year":"2001","journal-title":"Neuroscience."},{"key":"10.1016\/j.nbd.2019.104526_bb1020","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.1523\/JNEUROSCI.22-17-07825.2002","article-title":"Abnormal cerebellar signaling induces dystonia in mice","volume":"22","author":"Pizoli","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb1025","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/sj.bjp.0703366","article-title":"Adenosine receptor expression and function in rat striatal cholinergic interneurons","volume":"130","author":"Preston","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2019.104526_bb1030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.expneurol.2012.11.019","article-title":"Neuropathology of cervical dystonia","volume":"241","author":"Prudente","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2019.104526_bb1035","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fneur.2016.00201","article-title":"A functional magnetic resonance imaging study of head movements in cervical dystonia","volume":"7","author":"Prudente","year":"2016","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.nbd.2019.104526_bb1040","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1021\/acs.jmedchem.8b01810","article-title":"Discovery of an orally bioavailable and Central Nervous System (CNS) penetrant mGlu7 Negative Allosteric Modulator (NAM) in vivo tool compound: N-(2-(1H-1,2,4-triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3 -methoxybenzamide (VU6012962)","volume":"62","author":"Reed","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.nbd.2019.104526_bb1045","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nn1244","article-title":"Nicotine amplifies reward-related dopamine signals in striatum","volume":"7","author":"Rice","year":"2004","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb1050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-2999(02)02765-6","article-title":"The NMDA receptor NR2B subtype selective antagonist Ro 25-6981 aggravates paroxysmal dyskinesia in the dt(sz) mutant","volume":"458","author":"Richter","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2019.104526_bb1060","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/sj.bjp.0704268","article-title":"Effects of adenosine receptor agonists and antagonists in a genetic animal model of primary paroxysmal dystonia","volume":"134","author":"Richter","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2019.104526_bb1065","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0014-2999(94)00490-0","article-title":"(+)-WIN 55,212-2, a novel cannabinoid receptor agonist, exerts antidystonic effects in mutant dystonic hamsters","volume":"264","author":"Richter","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2019.104526_bb1070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0014-2999(02)02477-9","article-title":"Effects of pharmacological manipulations of cannabinoid receptors on severity of dystonia in a genetic model of paroxysmal dyskinesia","volume":"454","author":"Richter","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2019.104526_bb1075","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa1207281","article-title":"Brain dopamine-serotonin vesicular transport disease and its treatment","volume":"368","author":"Rilstone","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2019.104526_bb1080","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.neuron.2016.11.012","article-title":"Functional genomic analyses of mendelian and sporadic disease identify impaired eif2alpha signaling as a generalizable mechanism for dystonia","volume":"92","author":"Rittiner","year":"2016","journal-title":"Neuron."},{"key":"10.1016\/j.nbd.2019.104526_bb1085","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1046\/j.1460-9568.2002.02280.x","article-title":"Molecular phenotype of rat striatal neurons expressing the dopamine D5 receptor subtype","volume":"16","author":"Rivera","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb1090","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s00018-010-0293-y","article-title":"The dopamine D4 receptor: biochemical and signalling properties","volume":"67","author":"Rondou","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.nbd.2019.104526_bb1095","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/brain\/awv212","article-title":"A new knock-in mouse model of l-DOPA-responsive dystonia","volume":"138","author":"Rose","year":"2015","journal-title":"Brain."},{"key":"10.1016\/j.nbd.2019.104526_bb1100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3233\/JHD-170283","article-title":"Cannabinoids for treatment of dystonia in Huntington's disease","volume":"7","author":"Saft","year":"2018","journal-title":"J Huntingtons Dis."},{"key":"10.1016\/j.nbd.2019.104526_bb1105","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejphar.2007.01.067","article-title":"Effects of intrastriatal injections of glutamate receptor antagonists on the severity of paroxysmal dystonia in the dtsz mutant","volume":"563","author":"Sander","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2019.104526_bb1110","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.expneurol.2017.06.005","article-title":"Strength of cholinergic tone dictates the polarity of dopamine D2 receptor modulation of striatal cholinergic interneuron excitability in DYT1 dystonia","volume":"295","author":"Scarduzio","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2019.104526_bb1115","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1471-4159.1991.tb08257.x","article-title":"Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study","volume":"57","author":"Schiffmann","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2019.104526_bb1120","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/WCO.0000000000000580","article-title":"Dystonia as a network disorder: a concept in evolution","volume":"31","author":"Schirinzi","year":"2018","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.nbd.2019.104526_bb1125","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev-neuro-070918-050258","article-title":"The Theory and Neuroscience of Cerebellar Cognition","volume":"42","author":"Schmahmann","year":"2019","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb1130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/mds.22825","article-title":"Modulatory effects of 5Hz rTMS over the primary somatosensory cortex in focal dystonia--an fMRI-TMS study","volume":"25","author":"Schneider","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104526_bb1135","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0898-6568(03)00058-5","article-title":"Signalling from adenosine receptors to mitogen-activated protein kinases","volume":"15","author":"Schulte","year":"2003","journal-title":"Cell. Signal."},{"key":"10.1016\/j.nbd.2019.104526_bb1140","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ncl.2009.04.010","article-title":"Genetics and treatment of dystonia","volume":"27","author":"Schwarz","year":"2009","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.nbd.2019.104526_bb1145","doi-asserted-by":"crossref","first-page":"11991","DOI":"10.1523\/JNEUROSCI.0041-12.2012","article-title":"Cholinergic dysfunction alters synaptic integration between thalamostriatal and corticostriatal inputs in DYT1 dystonia","volume":"32","author":"Sciamanna","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb1150","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.neuropharm.2014.06.013","article-title":"Negative allosteric modulation of mGlu5 receptor rescues striatal D2 dopamine receptor dysfunction in rodent models of DYT1 dystonia","volume":"85","author":"Sciamanna","year":"2014","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.nbd.2019.104526_bb1155","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s12311-016-0825-6","article-title":"Current opinions and areas of consensus on the role of the cerebellum in dystonia","volume":"16","author":"Shakkottai","year":"2017","journal-title":"Cerebellum."},{"key":"10.1016\/j.nbd.2019.104526_bb1160","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3389\/fneur.2018.01008","article-title":"Stereotactic lesioning of the thalamic vo nucleus for the treatment of writer's cramp (focal hand dystonia)","volume":"9","author":"Shimizu","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2019.104526_bb1165","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0165-6147(92)90025-2","article-title":"Molecular biology of dopamine receptors","volume":"13","author":"Sibley","year":"1992","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2019.104526_bb1170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.irn.2018.09.007","article-title":"Neuroimaging Applications in Dystonia","volume":"143","author":"Simonyan","year":"2018","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.nbd.2019.104526_bb1175","doi-asserted-by":"crossref","first-page":"14705","DOI":"10.1523\/JNEUROSCI.0407-13.2013","article-title":"Abnormal striatal dopaminergic neurotransmission during rest and task production in spasmodic dysphonia","volume":"33","author":"Simonyan","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb1180","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1093\/brain\/awx263","article-title":"The direct basal ganglia pathway is hyperfunctional in focal dystonia","volume":"140","author":"Simonyan","year":"2017","journal-title":"Brain."},{"key":"10.1016\/j.nbd.2019.104526_bb1185","doi-asserted-by":"crossref","first-page":"559","DOI":"10.5334\/tohm.437","article-title":"risk factor genes in patients with dystonia: a comprehensive review","volume":"8","author":"Siokas","year":"2018","journal-title":"Tremor Other Hyperkinet Mov (N Y)."},{"key":"10.1016\/j.nbd.2019.104526_bb1190","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/bph.13716","article-title":"The evolution of regulators of G protein signalling proteins as drug targets - 20 years in the making: IUPHAR review 21","volume":"174","author":"Sj\u00f6gren","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2019.104526_bb1195","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1111\/j.1460-9568.2008.06505.x","article-title":"Differences in excitatory transmission between thalamic and cortical afferents to single spiny efferent neurons of rat dorsal striatum","volume":"28","author":"Smeal","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb1200","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0140-6736(81)91064-3","article-title":"Bromocriptine in dystonia","volume":"2","author":"Stahl","year":"1981","journal-title":"Lancet."},{"key":"10.1016\/j.nbd.2019.104526_bb1205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cne.903430102","article-title":"Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat","volume":"343","author":"Standaert","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2019.104526_bb1210","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF00432269","article-title":"Benztropine prophylaxis of dystonic reactions","volume":"61","author":"Stern","year":"1979","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.nbd.2019.104526_bb1215","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.parkreldis.2005.05.001","article-title":"Levetiracetam for the treatment of generalized dystonia","volume":"11","author":"Sullivan","year":"2005","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2019.104526_bb1220","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.brainres.2019.01.021","article-title":"In vitro phosphodiesterase 10A (PDE10A) binding in whole hemisphere human brain using the PET radioligand [(18)F]MNI-659","volume":"1711","author":"Svedberg","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2019.104526_bb1225","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/jnnp.35.2.186","article-title":"Treatment of involuntary movement disorders with tetrabenazine","volume":"35","author":"Swash","year":"1972","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2019.104526_bb1230","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nrneurol.2009.160","article-title":"Primary dystonia: molecules and mechanisms","volume":"5","author":"Tanabe","year":"2009","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2019.104526_bb1235","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.neuron.2010.01.021","article-title":"The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission","volume":"65","author":"Tanimura","year":"2010","journal-title":"Neuron."},{"key":"10.1016\/j.nbd.2019.104526_bb1240","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cell.2016.06.032","article-title":"Complementary contributions of striatal projection pathways to action initiation and execution","volume":"166","author":"Tecuapetla","year":"2016","journal-title":"Cell."},{"key":"10.1016\/j.nbd.2019.104526_bb1245","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.brainresrev.2007.10.008","article-title":"Feedforward and feedback inhibition in neostriatal GABAergic spiny neurons","volume":"58","author":"Tepper","year":"2008","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.nbd.2019.104526_bb1250","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fnana.2010.00150","article-title":"Heterogeneity and diversity of striatal GABAergic interneurons","volume":"4","author":"Tepper","year":"2010","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.nbd.2019.104526_bb1255","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/mds.27123","article-title":"It's not just the basal ganglia: cerebellum as a target for dystonia therapeutics","volume":"32","author":"Tewari","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.104526_bb1260","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s13311-013-0231-4","article-title":"Treatment of dystonia","volume":"11","author":"Thenganatt","year":"2014","journal-title":"Neurotherapeutics."},{"key":"10.1016\/j.nbd.2019.104526_bb1265","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1517\/14728222.2011.641533","article-title":"Convergent mechanisms in etiologically-diverse dystonias","volume":"15","author":"Thompson","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.nbd.2019.104526_bb1270","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fnsys.2011.00011","article-title":"Dopamine signaling in dorsal versus ventral striatum: the dynamic role of cholinergic interneurons","volume":"5","author":"Threlfell","year":"2011","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb1275","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1523\/JNEUROSCI.5620-09.2010","article-title":"Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum","volume":"30","author":"Threlfell","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb1280","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1073\/pnas.88.17.7491","article-title":"Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor","volume":"88","author":"Tiberi","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2019.104526_bb1285","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/mds.26659","article-title":"A phase 2a trial of the novel mGluR5-negative allosteric modulator dipraglurant for levodopa-induced dyskinesia in Parkinson's disease","volume":"31","author":"Tison","year":"2016","journal-title":"Mov. Disord."},{"issue":"Suppl. 7","key":"10.1016\/j.nbd.2019.104526_bb1290","first-page":"Vii7","article-title":"Dystonia in Parkinson's disease","volume":"253","author":"Tolosa","year":"2006","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2019.104526_bb1295","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.nbd.2019.104526_bb1300","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tips.2008.11.006","article-title":"RGS9-2: probing an intracellular modulator of behavior as a drug target","volume":"30","author":"Traynor","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2019.104526_bb1305","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1523\/JNEUROSCI.0448-07.2007","article-title":"Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum","volume":"27","author":"Uchigashima","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb1310","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/35041572","article-title":"Distinct functions of the two isoforms of dopamine D2 receptors","volume":"408","author":"Usiello","year":"2000","journal-title":"Nature."},{"key":"10.1016\/j.nbd.2019.104526_bb1315","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1091\/mbc.e09-01-0094","article-title":"LULL1 retargets torsinA to the nuclear envelope revealing an activity that is impaired by the DYT1 dystonia mutation","volume":"20","author":"Vander Heyden","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.nbd.2019.104526_bb1320","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(05)63142-X","article-title":"Treatment of spastic dystonia with transdermal nicotine","volume":"350","author":"Vaughan","year":"1997","journal-title":"Lancet."},{"key":"10.1016\/j.nbd.2019.104526_bb1325","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3389\/fneur.2017.00702","article-title":"a meta-analysis of adenosine A2A receptor antagonists on levodopa-induced dyskinesia In Vivo","volume":"8","author":"Wang","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2019.104526_bb1330","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.1073\/pnas.87.18.7050","article-title":"Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia","volume":"87","author":"Weiner","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2019.104526_bb1335","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1046\/j.1471-4159.1996.66031240.x","article-title":"Developmental and regional expression of NMDA receptor subtypes containing the NR2D subunit in rat brain","volume":"66","author":"Wenzel","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2019.104526_bb1340","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1471-4159.1997.68020469.x","article-title":"NMDA receptor heterogeneity during postnatal development of the rat brain: differential expression of the NR2A, NR2B, and NR2C subunit proteins","volume":"68","author":"Wenzel","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2019.104526_bb1345","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.expneurol.2008.04.020","article-title":"Commentary: dopaminergic dysfunction in DYT1 dystonia","volume":"212","author":"Wichmann","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2019.104526_bb1350","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1021\/acsmedchemlett.6b00461","article-title":"Discovery of VU0467485\/AZ13713945: an M4 PAM evaluated as a preclinical candidate for the treatment of schizophrenia","volume":"8","author":"Wood","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.nbd.2019.104526_bb1355","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.celrep.2014.12.005","article-title":"Input- and cell-type-specific endocannabinoid-dependent LTD in the striatum","volume":"10","author":"Wu","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2019.104526_bb1360","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0404.2006.00624.x","article-title":"Levetiracetam in Meige's syndrome","volume":"114","author":"Yardimci","year":"2006","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.nbd.2019.104526_bb1365","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.baga.2011.04.002","article-title":"Cannabinoid, CB1 agonists in cervical dystonia: failure in a phase IIa randomized controlled trial","volume":"1","author":"Zadikoff","year":"2011","journal-title":"Basal Ganglia."},{"key":"10.1016\/j.nbd.2019.104526_bb1370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007169","article-title":"Mutations in THAP1\/DYT6 reveal that diverse dystonia genes disrupt similar neuronal pathways and functions","volume":"14","author":"Zakirova","year":"2018","journal-title":"PLoS Genet."},{"key":"10.1016\/j.nbd.2019.104526_bb1375","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1523\/JNEUROSCI.22-15-06347.2002","article-title":"Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice","volume":"22","author":"Zhang","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb1380","doi-asserted-by":"crossref","first-page":"Rc91","DOI":"10.1523\/JNEUROSCI.20-16-j0001.2000","article-title":"G(olf)alpha mediates dopamine D1 receptor signaling","volume":"20","author":"Zhuang","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104526_bb1385","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fnsys.2017.00043","article-title":"Evaluation of AZD1446 as a Therapeutic in DYT1 Dystonia","volume":"11","author":"Zimmerman","year":"2017","journal-title":"Front. Syst. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996119301949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996119301949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:21:21Z","timestamp":1760851281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996119301949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":276,"alternative-id":["S0969996119301949"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2019.104526","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The neurobiological basis for novel experimental therapeutics in dystonia","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2019.104526","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104526"}}